Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans

Diabetologia

Volumn 51, Issue 6, 2008, Pages 1018-1024

  Ahren B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autonomic nerves; Dexamethasone; Humans; Insulin secretion; Parasympathetic nerves; Trimethaphan

Indexed keywords

ARGININE; DEXAMETHASONE; GLUCOSE; INSULIN; TRIMETAPHAN;

AGED; ARTICLE; AUTONOMIC INNERVATION; BODY MASS; FEMALE; GANGLION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL;

ARGININE; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; DEXAMETHASONE; FEMALE; GLUCOSE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; KINETICS; MIDDLE AGED; POSTMENOPAUSE;

EID: 43049135469     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0995-y     Document Type: Article

References (37)

1. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man. Measurements of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
2. Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and b-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
3. Ahrén B, Pacini G (2005) Islet adaptation to insulin resistance: mechanisms and implications for intervention. Diabetes Obes Metab 7:2-8
4. Larsson H, Ahrén B (1996) Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39:1099-1107
5. Ahrén B, Pacini G (1997) Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 273:E701-E707
6. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
7. Kahn SE, Beard JC, Schwartz MW et al (1989) Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38:562-568
8. Larsson H, Ahrén B (1999) Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity. Diabetologia 42:936-943
9. Dobbins RI, Chester MW, Daniels MB et al (1998) Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47:1613-1618
10. Zhou VP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876
11. Ahrén B (2000) Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43:393-410
12. Ahrén B, Wierup N, Sundler F (2006) Neuropeptides and the regulation of islet function. Diabetes 55(Suppl 2):S98-S107
13. Ahrén B, Lundquist I (1982) Modulation of basal insulin secretion in the obese, hyperglycemic, mouse. Metabolism 31:172-179
14. Rohner-Jeanrenaud F, Hochstrasser AC, Jeanrenaud B (1983) Hyperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Am J Physiol 244:E317-E322
15. Ahrén B, Sauerberg P, Thomsen C (1999) Increased insulin secretion and normalisation of glucose tolerance by cholinergic agonism in high-fat fed C57BL/6J mice. Am J Phyisol 277:E93-E102
16. Schwartz TW, Holst JJ, Fahrenkrug J (1978) Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61:781-789
17. Havel PJ, Taborsky GJ Jr (1989) The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycaemic stress. Endocr Rev 10:332-350
18. Weyer C, Salbe AD, Lindsay RS (2001) Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 50:223-230
19. Tong J, Utzschneider KM, Carr DB (2007) Plasma pancreatic polypeptide levels are associated with differences in body fat distribution in human subjects. Diabetologia 50:439-442
20. Taylor P (1985) Ganglionic stimulating and blocking agents. In: Gilman AD, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 215-221
21. Havel PJ, Ahrén B (1997) Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycaemia in women. Diabetes 46:801-807
22. Ahrén B, Holst JJ (2001) The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50:1030-1038
23. Ward WK, Bolgiano DC, McKnight B (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328
24. Larsson H, Ahrén B (1998) Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41:1772-1777
25. Beard JC, Halter JB, Best JD et al (1984) Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol 247:E592-E596
26. Fletcher JM, McKenzie N (1988) The parasympathetic nervous system and glucocorticoid-mediated hyperinsulinaemia in the genetically obese/fa/fa) obese rodents. J Endocrinol 118:87-92
27. Sainsbury A, Rohner-Jeanrenaud F, Cusin I (1977) Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary- adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40:1269-1277
28. DePirro R, Bertolli A, Fusco A (1980) Effect of dexamethasone and cortisone on insulin receptors in normal human male. J Clin Endocrinol Metab 51:503-507
29. Groop PH, Groop LC, Tötterman KJ, Fyhrquist F (1987) The effect of dexamethasone on the enteroinsular axis. Scand J Clin Lab Invest 47:491-495
30. Ludvik B, Clodi M, Kautzki-Willer A et al (1993) Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia 36:84-87
31. Larsson H, Ahrén B (2000) Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 23:650-657
32. Ahrén B, Larsson H (2002) Quantification of insulin secretion in relation to insulin sensitivity in non-diabetic post-menopausal women. Diabetes 52(Suppl 1):S202-S211
33. Lambillotte C, Gilon P, Henquin JC (1997) Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99:414-423
34. Ling ZC, Khan A, Delauyny F et al (1998) Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose-6-phosphatase, glucose cycling and insulin release. Diabetologia 41:634-639
35. Vozarova de Courten B, Weyer C et al (2004) Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians. Diabetes 53:663-671
36. Kreier F, Fliers E, Voshol PJ et al (2002) Selective parasympathetic innervation of subcutaneous and intraabdominal fat-functional implications. J Clin Invest 110:1243-1250
37. Peterson HR, Rotschild M, Weinberg CR et al (1988) Body fat and the activity of the autonomic nervous system. N Engl J Med 318:1077-1083